BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thakur TS, Thakuria R. Crystalline Multicomponent Solids: An Alternative for Addressing the Hygroscopicity Issue in Pharmaceutical Materials. Crystal Growth & Design 2020;20:6245-65. [DOI: 10.1021/acs.cgd.0c00654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Saikia B, Pathak D, Sarma B. Variable stoichiometry cocrystals: occurrence and significance. CrystEngComm 2021;23:4583-606. [DOI: 10.1039/d1ce00451d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
2 Rathi R, Singh I. Multicomponent crystal compromising dasatinib and selected co-crystals formers: a patent evaluation of EP2861589B1. Pharm Pat Anal 2022. [PMID: 35172634 DOI: 10.4155/ppa-2021-0024] [Reference Citation Analysis]
3 Cadden J, Gupta KM, Kanaujia P, Coles SJ, Aitipamula S. Cocrystal Formulations: Evaluation of the Impact of Excipients on Dissolution by Molecular Simulation and Experimental Approaches. Crystal Growth & Design 2021;21:1006-18. [DOI: 10.1021/acs.cgd.0c01351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Tamboli MI, Okamoto Y, Utsumi Y, Furuishi T, Wang S, Umeda D, Putra OD, Fukuzawa K, Uekusa H, Yonemochi E. Crystal Structures of Antiarrhythmic Drug Disopyramide and Its Salt with Phthalic Acid. Crystals 2021;11:379. [DOI: 10.3390/cryst11040379] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun J, Jia L, Wang M, Liu Y, Li M, Han D, Gong J. Novel Drug–Drug Multicomponent Crystals of Epalrestat–Metformin: Improved Solubility and Photostability of Epalrestat and Reduced Hygroscopicity of Metformin. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.1c00810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhang Y, Li Y, Liu L, Guo Q, Sa R, Zhang M, Lou B. Two Cocrystal Polymorphs of Palmatine Chloride with Racemic Hesperetin. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.1c01016] [Reference Citation Analysis]
7 Liu L, Wang J, Mei X. Enhancing the stability of active pharmaceutical ingredients by the cocrystal strategy. CrystEngComm. [DOI: 10.1039/d1ce01327k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
8 Allu S, Garai A, Chernyshev VV, Nangia AK. Synthesis of Ternary Cocrystals, Salts, and Hydrates of Acefylline with Enhanced Dissolution and High Permeability. Crystal Growth & Design 2022;22:4165-81. [DOI: 10.1021/acs.cgd.2c00184] [Reference Citation Analysis]
9 Fujito T, Oshima T, Higashi K, Ueda K, Ito M, Masu H, Noguchi S, Moribe K. Salt Cocrystallization of Loxoprofen Sodium with Sugar: Reduction of the Propensity for Hydrate Formation by Forming a Continuous One-Dimensional Chain Structure of Sodium and Sugar. Crystal Growth & Design 2022;22:1094-103. [DOI: 10.1021/acs.cgd.1c01050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bofill L, de Sande D, Barbas R, Prohens R. A New and Highly Stable Cocrystal of Vitamin D3 for Use in Enhanced Food Supplements. Crystal Growth & Design 2021;21:1418-23. [DOI: 10.1021/acs.cgd.0c01709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Deka P, Gogoi D, Althubeiti K, Rao DR, Thakuria R. Mechanosynthesis, Characterization, and Physicochemical Property Investigation of a Favipiravir Cocrystal with Theophylline and GRAS Coformers. Crystal Growth & Design 2021;21:4417-25. [DOI: 10.1021/acs.cgd.1c00339] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kumari N, Roy P, Roy S, Parmar PK, Chakraborty S, Das S, Pandey N, Bose A, Bansal AK, Ghosh A. Investigating the Role of the Reduced Solubility of the Pirfenidone-Fumaric Acid Cocrystal in Sustaining the Release Rate from Its Tablet Dosage Form by Conducting Comparative Bioavailability Study in Healthy Human Volunteers. Mol Pharm 2022. [PMID: 35290064 DOI: 10.1021/acs.molpharmaceut.2c00052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Huang G, Yang L, Ren B, Lv X, Song L, Dai X, Chen J. Simultaneously improving the physicochemical and pharmacokinetic properties of vemurafenib through cocrystallization strategy. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103230] [Reference Citation Analysis]
14 Gundlapalli S, Devarapalli R, Mudda RR, Chennuru R, Rupakula R. Novel solid forms of insomnia drug suvorexant with improved solubility and dissolution: accessing salts from a salt solvate route. CrystEngComm 2021;23:7739-49. [DOI: 10.1039/d1ce01269j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wu D, Li J, Xiao Y, Ji X, Li C, Zhang B, Hou B, Zhou L, Xie C, Gong J, Chen W. New Salts and Cocrystals of Pymetrozine with Improvements on Solubility and Humidity Stability: Experimental and Theoretical Study. Crystal Growth & Design 2021;21:2371-88. [DOI: 10.1021/acs.cgd.1c00009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
16 Davies RD, Vigilante NJ, Frederick AD, Mandala VS, Mehta MA. The Effects of Humidity on Spontaneous Cocrystallization: A Survey of Diacid Cocrystals with Caffeine, Theophylline, and Nicotinamide. J Chem Crystallogr. [DOI: 10.1007/s10870-022-00922-8] [Reference Citation Analysis]
17 Kaliszczak M, Durand P, Wenger E, Dossot M, Jones F, Arrigan DWM, Herzog G. Electrochemically controlled cocrystallisation of caffeine:1-hydroxy-2-naphthoic acid. CrystEngComm 2021;24:48-51. [DOI: 10.1039/d1ce01281a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li M, Sun J, Kuang W, Zhou L, Han D, Gong J. Drug–Drug Multicomponent Crystals of Epalrestat: A Novel Form of the Drug Combination and Improved Solubility and Photostability of Epalrestat. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.2c00533] [Reference Citation Analysis]
19 Bordignon S, Cerreia Vioglio P, Bertoncini C, Priola E, Gobetto R, Chierotti MR. Pseudopolymorphism Driven by Stoichiometry and Hydrated/Anhydrous Reagents: The Riveting Case of Methyl Gallate· l -Proline. Crystal Growth & Design 2021;21:6776-85. [DOI: 10.1021/acs.cgd.1c00680] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Djaló M, Cunha AES, Luís JP, Quaresma S, Fernandes A, André V, Duarte MT. Sparfloxacin Multicomponent Crystals: Targeting the Solubility of Problematic Antibiotics. Crystal Growth & Design 2021;21:995-1005. [DOI: 10.1021/acs.cgd.0c01346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
21 Beyer KD. Deliquescence Relative Humidity and Reversible Non-deliquescent Water Uptake in the Sodium Salts of Succinic Acid. ACS Earth Space Chem 2021;5:2280-90. [DOI: 10.1021/acsearthspacechem.1c00168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Saladi VN, Kammari BR, Mandad PR, Krishna GR, Sajja E, Thirumali RS, Marutapilli A, Mathad VT. Novel Pharmaceutical Cocrystal of Apalutamide, a Nonsteroidal Antiandrogen Drug: Synthesis, Crystal Structure, Dissolution, Stress, and Excipient Compatibility. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.1c01087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]